PeptiMed, Inc.
PeptiMed, Inc. is a Madison, Wisconsin-based biotechnology company that develops therapeutic drugs targeting the EVI1 gene for the treatment of skin, breast, lung, prostate, and ovarian cancers.
2
Funding Rounds
$500.0k
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Sc*** Sc******* | - | - | |
| Ni****** Pr****** | - | - | - |
Industries
PeptiMed, Inc. is active in the following industries: